Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.

Johansson, Henrik J; Sanchez, Betzabe C; Forshed, Jenny; Stål, Olle; Fohlin, Helena; Lewensohn, Rolf; Hall, Per; Bergh, Jonas; Lehtiö, Janne; Linderholm, Barbro K

Johansson, Henrik J; Sanchez, Betzabe C; Forshed, Jenny; Stål, Olle; Fohlin, Helena; Lewensohn, Rolf; Hall, Per; Bergh, Jonas; Lehtiö, Janne; Linderholm, Barbro K.

Afiliação

Johansson HJ; Department Oncology-Pathology, Cancer Proteomics Mass spectrometry, Science for Life Laboratory, Karolinska Institutet, SE-171 65 Stockholm, Sweden.
Sanchez BC; Department Oncology-Pathology, Cancer Proteomics Mass spectrometry, Science for Life Laboratory, Karolinska Institutet, SE-171 65 Stockholm, Sweden.
Forshed J; Department Oncology-Pathology, Cancer Proteomics Mass spectrometry, Science for Life Laboratory, Karolinska Institutet, SE-171 65 Stockholm, Sweden.
Stål O; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
Fohlin H; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden ; Regional cancer center Southeast Sweden, County Council of Östergötland, Linköping, Sweden.
Lewensohn R; Department of Oncology, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, Stockholm, 17177 Sweden.
Bergh J; Department Oncology-Pathology, Cancer Proteomics Mass spectrometry, Science for Life Laboratory, Karolinska Institutet, SE-171 65 Stockholm, Sweden.
Lehtiö J; Department Oncology-Pathology, Cancer Proteomics Mass spectrometry, Science for Life Laboratory, Karolinska Institutet, SE-171 65 Stockholm, Sweden.
Linderholm BK; Department Oncology-Pathology, Cancer Proteomics Mass spectrometry, Science for Life Laboratory, Karolinska Institutet, SE-171 65 Stockholm, Sweden ; Department of Oncology, Sahlgrenska Academy and University Hospital, SE-413 45 Gothenburg, Sweden.

Clin Proteomics ; 12(1): 8, 2015.

Article em En | MEDLINE | ID: mdl-25878567

Palavras-chave

CAPS; Calcyphosine; Endocrine resistance; Estrogen receptor; MX1; Proteomics; Receptor-positive breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Proteomics Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google